imBio
Minneapolis, US · Michigan LLC · 1 known investors
Find your way into imBio
290 people in our graph share verified history with the imBio team — schools, employers, funds. One of them is your warm intro.
Dougunlockedknows David Hannes · together at University of Wisconsin-Madison (overlapped)
×5knows the team · via Ford Motor
×2knows the team · via University of Wisconsin-Madison
×4knows the team · via University of Dayton
Founders & leadership
DH
David HannesinExecutiveDavid Hannes brings two decades of experience in commercial, service, and operations leadership at medical device companies ranging from early-stage to Fortune 50 firms. He has led both new business development and performance improvements for established organizations.
TD
Troy D. KopischkeExecutive
CM
Cynthia MaierExecutive
MS
Mark SylvesterExecutive
DJ
Danny J. CunaginExecutive
AR
Alnawaz Rehemtulla, M.D.Named on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2015
▶$1.1MraisedSep 2015 · 1 investors · Other TechnologyRule 506(b)
▶$1.1MraisedSep 2015 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alnawaz Rehemtulla, M.D.Director
- David HannesExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Cynthia MaierExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Danny J. CunaginExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Inari Medical7 shared keywordsInari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
Globaldata7 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Read the Press Release7 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Companies competing with imBio for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $251.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $166.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $222.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $179.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $150.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $144.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are imBio's investors?
- imBio's investors include Seneca Partners.
- How much funding has imBio raised?
- imBio has disclosed $1.1M raised across 1 round.
- Where is imBio headquartered?
- imBio is headquartered in Minneapolis, US.